<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03053193</url>
  </required_header>
  <id_info>
    <org_study_id>FLEX Registry</org_study_id>
    <nct_id>NCT03053193</nct_id>
  </id_info>
  <brief_title>MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles</brief_title>
  <acronym>FLEX</acronym>
  <official_title>MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Agendia</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Agendia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The FLEX Registry will be implemented to operate as a large-scale, population based,
      prospective registry. All patients with stage I to III breast cancer who receive MammaPrint®
      and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX
      Registry, which is intended to enable additional study arms at low incremental effort and
      cost. FLEX Registry will utilize an adaptive design, where additional targeted substudies and
      arms can be added after the initial study is opened.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The FLEX Registry will include all patients with stage I-III breast cancer who have received
      MammaPrint and BluePrint testing in any clinical setting. Study arm appendices will specify
      treatment arm, inclusion criteria, and number of patients needed. Approximately 2000 patients
      from 70-75 US based institutions will be enrolled.

      Treatment is at the discretion of the physician adhering to NCCN approved regimens of a
      recognized alternative.

      Clinical data will be collected and entered online at the time points listed: patient
      enrollment, time of treatment, 1 year post-treatment, and 2, 5, and 10 years post diagnosis.

      Objectives:

        -  Create a large scale, population-based registry of full genome expression data and
           clinical data to investigate new gene associations with prognostic and/or predictive
           value

        -  Utilize shared registry infrastructure to examine smaller groups of interest

        -  Generate hypotheses for targeted subset analyses and trials based on full genome data
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 28, 2017</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">April 2027</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>A large scale registry of full genome expression data to investigate new gene associations with prognostic and/or predictive value will be created.</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>A shared registry infrastructure to examine smaller groups of interest.</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subset analyses based on full genome data will be created.</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>MammaPrint and BluePrint testing</arm_group_label>
    <description>All patients will receive MammaPrint and BluePrint testing using the full-genome testing data chip. Treatment will be at the discretion of the physician while adhering to NCCN guidelines.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MammaPrint, BluePrint, and Full-Genome Testing</intervention_name>
    <description>Agendia will run MammaPrint and BluePrint tests using the DiscoverPrint testing array.</description>
    <arm_group_label>MammaPrint and BluePrint testing</arm_group_label>
    <other_name>MammaPrint, BluePrint, DiscoverPrint</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tumor tissue acquired as part of a standard of care biopsy or surgical procedure will be sent
      to Agendia for testing.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will include patients with stage I to III breast cancer that have signed
        an informed consent, and are eligible to receive chemotherapy and endocrine therapy as
        defined by a good karnofsky index. Patients will be excluded if they have metastatic
        disease or do not have ample tissue to send to Agendia for testing.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage I-III patients with a MammaPrint and BluePrint result (male or female)

          -  Informed consent form signed on the same day or before enrollment

          -  Eligible to receive chemotherapy and endocrine therapy as defined by a good Karnofsky
             index (≥80)

        Exclusion Criteria:

        Participants are excluded from the study if any of the following criteria apply: • Tumor
        sample shipped to Agendia with ≤ 30% tumor cells or that fails QA or QC criteria

        • Metastatic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George Somlo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>City of Hope Duarte - Comprehensive Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Untch, MS</last_name>
    <phone>412-770-6906</phone>
    <email>sarah.untch@agendia.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Comprehensive Cancer Center at Desert Regional Medical Center</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <zip>92262</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Fortiche</last_name>
      <email>claudia.fortiche@tenethealth.com</email>
    </contact>
    <investigator>
      <last_name>Laura Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Valley Breast Clinic</name>
      <address>
        <city>Redding</city>
        <state>California</state>
        <zip>96001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian Grady, MD</last_name>
      <phone>530-243-5551</phone>
    </contact>
    <investigator>
      <last_name>Ian P Grady, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Valley Breast Care</name>
      <address>
        <city>Van Nuys</city>
        <state>California</state>
        <zip>91405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Dunham</last_name>
      <email>james@valleybreastcare.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Lomis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comprehensive Breast Care of Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Ruybal, MA</last_name>
      <email>Joseph.Ruybal@sclhs.net</email>
    </contact>
    <investigator>
      <last_name>Julie Barone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Morton Plant Hospital</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Ellis, RN</last_name>
      <phone>727-461-8526</phone>
      <email>Debra.Ellis@Baycare.org</email>
    </contact>
    <investigator>
      <last_name>Peter Blumencranz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lakeland Regional Cancer Center</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Delph</last_name>
      <email>Rebecca.Delph@myLRH.org</email>
    </contact>
    <investigator>
      <last_name>Madhavi Venigalla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Winter Haven Hospital</name>
      <address>
        <city>Winter Haven</city>
        <state>Florida</state>
        <zip>33881</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Bauer, RN</last_name>
      <phone>863-293-1121</phone>
      <phone_ext>5872</phone_ext>
      <email>Janet.Bauer@baycare.org</email>
    </contact>
    <investigator>
      <last_name>Kamal Sharma, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Cancer Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30318</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Trevor Feinstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DeKalb Medical Center</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruthie Sweat</last_name>
      <email>Ruthie.Sweat@dekalbmedical.org</email>
    </contact>
    <investigator>
      <last_name>Jayanthi Srinivasiah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tift Regional Health System</name>
      <address>
        <city>Tifton</city>
        <state>Georgia</state>
        <zip>31794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jodie Davis, RN</last_name>
      <phone>229-353-3730</phone>
      <email>Jodie.Davis@tiftregional.com</email>
    </contact>
    <investigator>
      <last_name>Apurva Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana State University</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camille Fournet</last_name>
      <email>mfourn@lsuhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Lucio Miele, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Agustin Garcia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Riker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa McConnell</last_name>
      <email>lmcconnell@mdmercy.com</email>
    </contact>
    <investigator>
      <last_name>David Riseberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Maryland Health System</name>
      <address>
        <city>Cumberland</city>
        <state>Maryland</state>
        <zip>21502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mildred Seletyn</last_name>
      <email>mseletyn@wmhs.com</email>
    </contact>
    <investigator>
      <last_name>Blanche Mavromatis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John Hospital</name>
      <address>
        <city>Grosse Pointe Woods</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret van der Veen, RN</last_name>
      <phone>313-343-4657</phone>
      <email>Margaret.Vanderveen@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Carrie Dul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sparrow Cancer Center</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harsha Trivedi</last_name>
      <email>harsha.trivedi@sparrow.org</email>
    </contact>
    <investigator>
      <last_name>Gordan Srkalovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Imlay</last_name>
      <phone>314-268-7058</phone>
      <email>anne.imlay@health.slu.edu</email>
    </contact>
    <investigator>
      <last_name>Yifan Tu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mary Klix, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ashikari Breast Center</name>
      <address>
        <city>Dobbs Ferry</city>
        <state>New York</state>
        <zip>10522</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julissa Cruz</last_name>
      <email>jcruz@riversidehealth.org</email>
    </contact>
    <investigator>
      <last_name>Pond Keleman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hematology Oncology Center of Rockland at Nyack</name>
      <address>
        <city>Nyack</city>
        <state>New York</state>
        <zip>10960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion VanWoudenberg</last_name>
      <email>research@highlandmedicalpc.com</email>
    </contact>
    <investigator>
      <last_name>Sung Ho Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Akron General Medical Center</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44307</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael McNeal</last_name>
      <email>michael.mcneal@akrongeneral.org</email>
    </contact>
    <investigator>
      <last_name>Esther Rehmus</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Cancer Specialists</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74146</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Byerly</last_name>
      <email>jan.byerly@ocsri.org</email>
    </contact>
    <investigator>
      <last_name>Melinda Dunlap, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Kachmarsky</last_name>
      <email>Carol.Kachmarsky@sluhn.org</email>
    </contact>
    <investigator>
      <last_name>Lee Riley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yolanda G. Barco Oncology Institute</name>
      <address>
        <city>Meadville</city>
        <state>Pennsylvania</state>
        <zip>16335</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Przepiora</last_name>
      <email>aprzepiora1@mmchs.org</email>
    </contact>
    <investigator>
      <last_name>Calvin Han, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Centers</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Thomas</last_name>
      <email>thomascr@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Adam Brufsky, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Roper St. Francis Physician Partners - Breast Surgery</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney O'Neill Roldan, MHA</last_name>
      <email>courtney.oneill@rsfh.com</email>
    </contact>
    <investigator>
      <last_name>Paul Baron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nashville Breast Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristie Appleton</last_name>
      <phone>615-620-5535</phone>
    </contact>
    <investigator>
      <last_name>Pat W Whitworth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRISTUS Spohn Cancer Center</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Polly Mock</last_name>
      <email>polly.mock@christushealth.org</email>
    </contact>
    <investigator>
      <last_name>Shantan Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Health Cancer Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lacey McClure</last_name>
      <email>McClureL1@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Virginia Kaklamani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2017</study_first_submitted>
  <study_first_submitted_qc>February 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2017</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>breast cancer</keyword>
  <keyword>stage I</keyword>
  <keyword>stage II</keyword>
  <keyword>stage III</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

